-
Je něco špatně v tomto záznamu ?
Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome – a description of two cases
Filip Gabalec, Alžběta Zavřelová, Eduard Havel, Jaroslav Cerman, jr., Jakub Radocha, Ioannis Svilias, Jan Čáp
Jazyk angličtina Země Česko
Typ dokumentu kazuistiky
Grantová podpora
NT11344
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Část
Číslo
Ročník
Zdroj
Zdroj
Zdroj
Free Medical Journals od 1997
Open Access Digital Library od 1997-01-01
ROAD: Directory of Open Access Scholarly Resources od 1997
- MeSH
- adrenokortikální hyperfunkce farmakoterapie MeSH
- Cushingův syndrom diagnóza farmakoterapie chirurgie MeSH
- glukokortikoidy aplikace a dávkování škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- Pneumocystis izolace a purifikace patogenita účinky léků MeSH
- pneumocystová pneumonie diagnóza farmakoterapie chemicky indukované MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- ženské pohlaví MeSH
- Publikační typ
- kazuistiky MeSH
Only a few cases of pneumocystis pneumonia (PCP) in Cushing's syndrome have been published in the literature so far. In the majority of these patients, the pneumonia occurred after reduction of the hypercortisolism with medicamentous treatment. We report two cases of PCP during conservative treatment of hypercortisolism. We describe clinical, imaging and laboratory findings in two patients and review published cases of pneumocystits pneumonia in Cushing's syndrome. A 60-year-old woman and 20-year-old man with Cushing's syndrome due to ectopic ACTH syndrome were treated at our department. Both developed pneumocystis pneumonia early after treatment with ketoconazole and ethomidate bromide had been introduced and the levels of cortisol rapidly decreased. PCP prophylaxis in patients with high cortisolemia should be started before treatment of hypercortisolism in current practice. Gradual lowering of plasma cortisol should also reduce the risk of infection by Pneumocystis jiroveci.
Obsahuje 1 tabulku
Bibliografie atd.Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12000522
- 003
- CZ-PrNML
- 005
- 20150119155751.0
- 007
- ta
- 008
- 120113s2011 xr o f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2016.35 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Gabalec, Filip $7 xx0108078 $u Charles University in Prague, Faculty of Medicine and University Hospital, Second Department of Internal Medicine, Hradec Králové
- 245 10
- $a Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome – a description of two cases / $c Filip Gabalec, Alžběta Zavřelová, Eduard Havel, Jaroslav Cerman, jr., Jakub Radocha, Ioannis Svilias, Jan Čáp
- 500 __
- $a Obsahuje 1 tabulku
- 504 __
- $a Literatura $b 10
- 520 9_
- $a Only a few cases of pneumocystis pneumonia (PCP) in Cushing's syndrome have been published in the literature so far. In the majority of these patients, the pneumonia occurred after reduction of the hypercortisolism with medicamentous treatment. We report two cases of PCP during conservative treatment of hypercortisolism. We describe clinical, imaging and laboratory findings in two patients and review published cases of pneumocystits pneumonia in Cushing's syndrome. A 60-year-old woman and 20-year-old man with Cushing's syndrome due to ectopic ACTH syndrome were treated at our department. Both developed pneumocystis pneumonia early after treatment with ketoconazole and ethomidate bromide had been introduced and the levels of cortisol rapidly decreased. PCP prophylaxis in patients with high cortisolemia should be started before treatment of hypercortisolism in current practice. Gradual lowering of plasma cortisol should also reduce the risk of infection by Pneumocystis jiroveci.
- 650 _2
- $a Cushingův syndrom $x diagnóza $x farmakoterapie $x chirurgie $7 D003480
- 650 _2
- $a glukokortikoidy $x aplikace a dávkování $x škodlivé účinky $7 D005938
- 650 _2
- $a pneumocystová pneumonie $x diagnóza $x farmakoterapie $x chemicky indukované $7 D011020
- 650 _2
- $a Pneumocystis $x izolace a purifikace $x patogenita $x účinky léků $7 D011010
- 650 _2
- $a adrenokortikální hyperfunkce $x farmakoterapie $7 D000308
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a ženské pohlaví $7 D005260
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Zavřelová, Alžběta. $7 xx0225108 $u Charles University in Prague, Faculty of Medicine and University Hospital, Second Department of Internal Medicine, Hradec Králové
- 700 1_
- $a Havel, Eduard, $d 1962- $7 xx0065539 $u Charles University in Prague, Faculty of Medicine and University Hospital, Department of Surgery, Hradec Králové
- 700 1_
- $a Cerman, Jaroslav $7 xx0127748 $u Charles University in Prague, Faculty of Medicine and University Hospital, Department of Surgery, Hradec Králové
- 700 1_
- $a Radocha, Jakub, $d 1981- $7 xx0233189 $u Charles University in Prague, Faculty of Medicine and University Hospital, Second Department of Internal Medicine, Hradec Králové
- 700 1_
- $a Svilias, Ioannis. $7 _AN065212 $u Charles University in Prague, Faculty of Medicine and University Hospital, Second Department of Internal Medicine, Hradec Králové
- 700 1_
- $a Čáp, Jan, $d 1953- $7 mzk2003190513 $u Charles University in Prague, Faculty of Medicine and University Hospital, Second Department of Internal Medicine, Hradec Králové
- 773 0_
- $t Acta medica (Hradec Králové) $x 1211-4286 $g Roč. 54, č. 3 (2011), s. 127-130 $w MED00010947
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2011053030127.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 2 $z 0
- 990 __
- $a 20120113150044 $b ABA008
- 991 __
- $a 20150119155938 $b ABA008
- 999 __
- $a ok $b bmc $g 893208 $s 757206
- BAS __
- $a 3
- BMC __
- $a 2011 $b 54 $c 3 $d 127-130 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- GRA __
- $a NT11344 $p MZ0
- LZP __
- $a 2012-03/dkmv